Company intelligence / Profile preview

Neuspera Medical

San Jose, California, United Statesneuspera.com ↗

Ownership: Private
Development stage: Phase 3

Overview

Neuspera’s integrated sacral neuromodulation system demonstrated “gold standard” efficacy comparable to established SNM therapies. In a pivotal Phase II study with 128 patients, 84.2% achieved at least a 50% reduction in urgent leaks and 84% of responders were "super responders" (>75% reduction). The device eliminates the need for an implanted battery, reducing surgical risks and improving patient comfort. FDA approval was granted in June 2025 for urinary urge incontinence

Therapeutic areas: NeurologyNephrologyUrology
Modalities: DeviceNeurostimulation deviceBioelectronic medicine device
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

Neuspera Implantable SNM System

Phase 3

Indications: Urinary urgency incontinence, Overactive bladder

Partnerships

Olympus Innovation Ventures is a strategic investor/partner as of July 2024 Series D financing round

Beyond the preview

Go deeper on Neuspera Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuspera Medical.

Explore the full profile